HCA Healthcare, Inc.
HCA Healthcare, Inc. (HCA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · HCA · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
14
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
HCA Healthcare, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
HCA insider buying and selling by quarter
HCA insider selling · HCA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · HCA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
HCA executive sell shares · HCA board member insider trading · HCA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 7, 2026 | Marks Mike A EVP and CFO | Gift | 3,336 | — | Form 4 |
| May 7, 2026 | Marks Mike A EVP and CFO | Gift | 3,336 | — | Form 4 |
| Apr 28, 2026 | Smith Andrea B Director | Award | 509 | — | Form 4 |
| Apr 28, 2026 | Riley Wayne Joseph Director | Award | 509 | — | Form 4 |
| Apr 28, 2026 | MICHELSON MICHAEL W Director | Award | 925 | — | Form 4 |
| Apr 28, 2026 | Johnston Hugh F Director | Award | 809 | — | Form 4 |
| Apr 28, 2026 | DEPARLE NANCY ANN Director | Award | 509 | — | Form 4 |
| Apr 28, 2026 | CHIDSEY JOHN Director | Award | 809 | — | Form 4 |
| Feb 13, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Option | 5,000 | $1.18M⚡ | Form 4 |
| Feb 13, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Other | 3,306 | $1.79M⚡ | Form 4 |
| Feb 18, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Sale | 1,694 | $904K | Form 4 |
| Feb 10, 2026 | Wyatt Christopher F. SVP & Controller | Award | 3,350 | — | Form 4 |
| Feb 10, 2026 | Wyatt Christopher F. SVP & Controller | Other | 1,034 | $519K | Form 4 |
| Feb 11, 2026 | Wyatt Christopher F. SVP & Controller | Sale | 4,000 | $2.02M⚡ | Form 4 |
| Feb 10, 2026 | Rossitto Erica SVP & Chief Nurse Executive | Award | 1,676 | — | Form 4 |
| Feb 10, 2026 | Rossitto Erica SVP & Chief Nurse Executive | Other | 418 | $210K | Form 4 |
| Feb 10, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Award | 8,372 | — | Form 4 |
| Feb 10, 2026 | McAlevey Michael R EVP & Chief Legal & Admin Off. | Other | 3,006 | $1.51M⚡ | Form 4 |
| Feb 10, 2026 | Marks Mike A EVP and CFO | Award | 5,026 | — | Form 4 |
| Feb 10, 2026 | Marks Mike A EVP and CFO | Other | 1,690 | $848K | Form 4 |
| Feb 10, 2026 | HAZEN SAMUEL N CEO · Director | Award | 54,934 | — | Form 4 |
| Feb 10, 2026 | HAZEN SAMUEL N CEO · Director | Other | 21,323 | $10.71M⚡ | Form 4 |
| Feb 10, 2026 | Foster Jon M EVP and COO | Award | 15,696 | — | Form 4 |
| Feb 10, 2026 | Foster Jon M EVP and COO | Other | 5,888 | $2.96M⚡ | Form 4 |
| Feb 10, 2026 | Cuffe Michael S. EVP and Chief Clinical Officer | Award | 9,628 | — | Form 4 |
McAlevey Michael R
EVP & Chief Legal & Admin Off.
Date
Feb 13
Shares
5,000
Price
$236.61
Value
$1.18M ⚡
McAlevey Michael R
EVP & Chief Legal & Admin Off.
Date
Feb 13
Shares
3,306
Price
$540.29
Value
$1.79M ⚡
McAlevey Michael R
EVP & Chief Legal & Admin Off.
Date
Feb 18
Shares
1,694
Price
$533.37
Value
$904K
Wyatt Christopher F.
SVP & Controller
Date
Feb 10
Shares
1,034
Price
$502.05
Value
$519K
Wyatt Christopher F.
SVP & Controller
Date
Feb 11
Shares
4,000
Price
$505.00
Value
$2.02M ⚡
Rossitto Erica
SVP & Chief Nurse Executive
Date
Feb 10
Shares
1,676
Price
—
Value
—
Rossitto Erica
SVP & Chief Nurse Executive
Date
Feb 10
Shares
418
Price
$502.05
Value
$210K
McAlevey Michael R
EVP & Chief Legal & Admin Off.
Date
Feb 10
Shares
8,372
Price
—
Value
—
McAlevey Michael R
EVP & Chief Legal & Admin Off.
Date
Feb 10
Shares
3,006
Price
$502.05
Value
$1.51M ⚡
HAZEN SAMUEL N
CEO · Director
Date
Feb 10
Shares
21,323
Price
$502.05
Value
$10.71M ⚡
Cuffe Michael S.
EVP and Chief Clinical Officer
Date
Feb 10
Shares
9,628
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About HCA insider trading
HCA insider trades
HCA Healthcare, Inc. (HCA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including HAZEN SAMUEL N (CEO · Director), McAlevey Michael R (EVP & Chief Legal & Admin Off.), Marks Mike A (EVP and CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. HCA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For HCA Healthcare, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
HCA insider trading · 5 questionsThe insiders of HCA Healthcare, Inc. (HCA) include executives and directors such as HAZEN SAMUEL N (CEO · Director), McAlevey Michael R (EVP & Chief Legal & Admin Off.), Marks Mike A (EVP and CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026